Sector Protalix BioTherapeutics, Inc.

Aandelen

PLX

US74365A3095

Farmaceutische producten

Beurs gesloten - 21:00:00 27-10-2026 Variatie 5 dagen Verschil t.o.v. 1 jan (%)
2,530 USD +2,02% Intraday-grafiek van Protalix BioTherapeutics, Inc. -1,17% +40,56%
Belangrijkste concurrenten
Verschil (%) Varia. 5d. Evolutie 1 maand Evolutie 3 maanden Var. 1 jan Varia. 1j. Varia. 3j. Varia. 5j. Varia. 10j. Kap.($)
+2,02%-1,17%-6,99%+6,75%+40,56%+7,20%+69,80%+123,89%-48,30% 200 mln.
+0,22%+3,35%+8,32%+7,18%+19,28%+55,30%+125,65%+415,98%+1.570,02% 1.140 mld.
+0,91%+5,89%-0,92%+2,02%+29,85%+41,14%+80,36%+62,13%+134,58% 641 mld.
-0,12%+1,31%+8,34%+10,42%+25,34%+25,62%+97,24%+161,57%+369,34% 507 mld.
+0,63%+4,97%+10,74%+12,36%+21,57%+47,12%+68,18%+11,47%+76,16% 383 mld.
+0,86%-1,26%-4,68%+8,20%+34,73%+62,10%+34,36%+72,43%+132,99% 347 mld.
+1,02%+3,69%+7,50%+1,48%+17,50%+23,73%+51,35%+65,38%+80,87% 293 mld.
-0,25%+3,40%+2,15%+1,20%-7,02%+2,31%+23,38%+42,42%+168,41% 266 mld.
+0,75%+5,41%+8,04%+19,12%+36,86%+53,53%+66,09%+114,66%+181,75% 240 mld.
+0,25%+3,93%+5,40%+23,02%+29,61%+31,54%+102,65%+134,87%+111,04% 197 mld.
-0,36%+1,17%+2,57%-19,06%-20,22%-24,14%-61,64%-24,30%+88,73% 172 mld.
+0,03%+1,22%+3,94%+21,43%+19,68%+20,36%-4,36%-31,59%-8,02% 170 mld.
+0,68%+3,80%-0,98%+9,15%+14,93%+23,65%+44,22%+183,06%+561,96% 131 mld.
-0,10%+4,62%-2,08%-0,87%+14,11%+40,43%+16,20%+5,68%+24,87% 126 mld.
-2,60%-4,30%+11,58%+15,00%+17,89%+20,63%+114,11%+364,98%+509,84% 116 mld.
+0,44%+3,69%+3,92%+0,21%+5,43%+18,73%+30,46%+7,29%-5,39% 102 mld.
+0,76%+5,83%+4,68%-1,16%-9,15%-15,36%-25,19%-12,26%+10,34% 99,92 mld.
+1,04%+4,36%+3,56%+24,40%+5,73%+41,21%+3,04%+37,82%+124,77% 80,65 mld.
+4,59%-8,34%+4,57%+284,63%+605,22%+677,75%+173,72%-39,85% - 79,39 mld.
-3,03%+5,59%+1,09%-9,82%-18,86%-3,56%+54,64%+57,33%+474,90% 72,02 mld.
Gemiddelde +0,33%+2,00%+3,54%+20,78%+44,15%+57,46%+53,21%+87,65%+239,94% 258,17 mld.
Gewogen gemiddelde per kap. +0,41%+2,71%+4,85%+11,46%+28,02%+45,66%+71,21%+149,33%+485,32%
  1. Beurs
  2. Aandelen
  3. Koers PLX
  4. Sector Protalix BioTherapeutics, Inc.